Avoid Fraud, Get The Facts, And Find The Best
Legal Name: FARALLON CAPITAL MANAGEMENT, L.L.C.
Period of report:
Jun 30, 2019
Effectiveness Date:
Aug 14, 2019
| Security |
Shares Held / Principal Amount |
Market Value |
Option |
|
AABA (021346101)
|
28,362,317 |
$1,967,494k |
|
|
SPDR S&P 500 ETF TR TR UNIT (78462F103)
|
3,647,500 |
$1,068,718k |
Put |
|
ANADARKO PETE (032511107)
|
10,465,000 |
$738,410k |
|
|
WABTEC (929740108)
|
6,568,373 |
$471,346k |
|
|
IQVIA HOLDINGS INC (46266C105)
|
2,579,011 |
$414,963k |
|
|
Array Biopharma Inc (04269X105)
|
8,500,000 |
$393,805k |
|
|
FIDELITY NATL INFO (31620M106)
|
2,842,640 |
$348,735k |
|
|
ANTHEM INC (036752103)
|
1,050,000 |
$296,321k |
|
|
CHARTER COMMUNICATIO (16119P108)
|
700,405 |
$276,786k |
|
|
GENERAL DYNAMICS (369550108)
|
1,335,214 |
$242,769k |
|
|
PLAYA HOTELS & RESOR (N70544106)
|
30,606,930 |
$235,979k |
|
|
IHS MARKIT LTD (G47567105)
|
3,604,997 |
$229,710k |
|
|
SHERWIN WILLIAMS CO (824348106)
|
465,699 |
$213,425k |
|
|
VISA INC COM CL A (92826C839)
|
1,187,779 |
$206,139k |
|
|
EQUIFAX INC (294429105)
|
1,463,779 |
$197,961k |
|
|
EQUINIX INC (29444U700)
|
383,132 |
$193,210k |
|
|
S&P GLOBAL INC (78409V104)
|
840,786 |
$191,523k |
|
|
CITRIX SYS INC (177376100)
|
1,916,051 |
$188,041k |
|
|
Booking Holdings, Inc. (09857L108)
|
97,449 |
$182,689k |
|
|
ASCENDIS PHARMA A S (04351P101)
|
1,540,000 |
$177,331k |
|
|
Facebook Inc (30303M102)
|
904,284 |
$174,527k |
|
|
ASTRAZENECA (046353108)
|
4,100,000 |
$169,248k |
|
|
MICROSOFT CORP (594918104)
|
1,257,503 |
$168,455k |
|
|
CIGNA CORP (125523100)
|
1,050,000 |
$165,428k |
|
|
Alphabet Inc (02079K107)
|
142,223 |
$153,730k |
|
|
Iovance Biotherapeutics Inc (462260100)
|
5,725,000 |
$140,377k |
|
|
TransUnion (89400J107)
|
1,672,343 |
$122,934k |
|
|
SEA LTD (81141R100)
|
3,375,000 |
$112,118k |
|
|
MIRATI THERAPEUTICS INC (60468T105)
|
995,000 |
$102,485k |
|
|
MYOKARDIA INC (62857M105)
|
2,000,000 |
$100,280k |
|
|
Acceleron Pharma Inc (00434H108)
|
2,375,000 |
$97,565k |
|
|
LIBERTY GLOBAL PLC (G5480U120)
|
3,675,974 |
$97,524k |
|
|
ZOGENIX INC (98978L204)
|
2,000,000 |
$95,560k |
|
|
ZAYO GROUP HLDGS INC (98919V105)
|
2,820,000 |
$92,806k |
|
|
Sage Therapeutics Inc (78667J108)
|
500,000 |
$91,545k |
|
|
ALIBABA GROUP HLDG LTD (01609W102)
|
500,000 |
$84,725k |
|
|
B. Riley Wealth Management, Inc. (023111206)
|
4,250,000 |
$82,408k |
|
|
ENANTA PHARMACEUTI (29251M106)
|
960,000 |
$81,005k |
|
|
ALNYLAM PHARMACEUTICALS INC (02043Q107)
|
1,100,000 |
$79,816k |
|
|
GENESEE & WYO INC (371559105)
|
775,000 |
$77,500k |
|
|
FIBROGEN INC (31572Q808)
|
1,700,000 |
$76,806k |
|
|
Sarepta Therapeutics Inc (803607100)
|
500,000 |
$75,975k |
|
|
NOVOCURE LTD (G6674U108)
|
1,200,000 |
$75,876k |
|
|
Reata Pharmaceuticals Inc. (75615P103)
|
800,000 |
$75,480k |
|
|
SPRINT CORPORATION (85207U105)
|
10,675,000 |
$70,135k |
|
|
GRIFOLS S A (398438408)
|
3,080,083 |
$64,990k |
|
|
EXELIXIS INC (30161Q104)
|
3,000,000 |
$64,110k |
|
|
GLOBAL BLOOD THERAPEUTICS IN (37890U108)
|
1,125,000 |
$59,175k |
|
|
LIBERTY GLOBAL PLC (G5480U104)
|
2,083,977 |
$56,247k |
|
|
ARROWHEAD PHARMACEUT (04280A100)
|
2,000,000 |
$53,000k |
|
|
Fate Therapeutics Inc (31189P102)
|
2,500,000 |
$50,750k |
|
|
RADIUS HEALTH INC (750469207)
|
2,043,149 |
$49,771k |
|
|
CVS HEALTH CORP (126650100)
|
822,500 |
$44,818k |
|
|
Fox Corp (35137L204)
|
1,182,500 |
$43,197k |
|
|
NXP Semiconductors NV (N6596X109)
|
430,000 |
$41,972k |
|
|
ZYMEWORKS INC (98985W102)
|
1,756,470 |
$38,642k |
|
|
FIRST DATA CORP (32008D106)
|
1,425,000 |
$38,575k |
|
|
PROGENICS PHARMACEUTICALS INCO (743187106)
|
5,543,386 |
$34,203k |
|
|
READY CAP CORP (75574U101)
|
2,243,239 |
$33,424k |
|
|
T MOBILE US INC COM USD0.00001 (872590104)
|
425,780 |
$31,567k |
|
|
FOX CORPORATION (35137L105)
|
836,400 |
$30,646k |
|
|
PTC THERAPEUTICS INC (69366J200)
|
600,000 |
$27,000k |
|
|
PTC THERAPEUTICS INC (69366JAB7)
|
24,130,000 |
$26,705k |
|
|
CRISPR Therapeutics AG (H17182108)
|
500,000 |
$23,550k |
|
|
QUOTIENT LTD COM NPV (G73268107)
|
2,500,000 |
$23,375k |
|
|
Codexis Inc (192005106)
|
1,250,000 |
$23,038k |
|
|
STEMLINE THERAPEUTICS INC (85858C107)
|
1,500,000 |
$22,980k |
|
|
SINA CORPORATION (G81477104)
|
510,000 |
$21,996k |
|
|
ZEALAND PHARMA A S (98920Y304)
|
1,000,000 |
$21,550k |
|
|
Invitae Corp (46185L103)
|
900,000 |
$21,150k |
|
|
CARA THERAPEUTICS (140755109)
|
951,326 |
$20,454k |
|
|
Voyager Therapeutics Inc (92915B106)
|
750,000 |
$20,415k |
|
|
CHEMOCENTRYX INC (16383L106)
|
2,000,000 |
$18,600k |
|
|
PROTAGONIST THERAPEUTICS INC (74366E102)
|
1,500,000 |
$18,165k |
|
|
AVROBIO INC (05455M100)
|
1,036,147 |
$16,848k |
|
|
CLOVIS ONCOLOGY INC (189464AC4)
|
18,750,000 |
$11,684k |
|
|
NanoString Technologies Inc (63009R109)
|
350,000 |
$10,623k |
|
|
Eiger Biopharmaceuticals Inc (28249U105)
|
1,000,000 |
$10,600k |
|
|
Voya Financial Inc. (929089100)
|
185,000 |
$10,231k |
|
|
Veracyte Inc (92337F107)
|
350,000 |
$9,979k |
|
|
PHASEBIO PHARMACEUTICALS INC (717224109)
|
756,961 |
$9,931k |
|
|
TWIST BIOSCIENCE CORP COM (90184D100)
|
307,055 |
$8,908k |
|
|
SAVARA INC (805111101)
|
3,475,000 |
$8,236k |
|
|
UNIQURE N.V. (N90064101)
|
100,000 |
$7,815k |
|
|
MILESTONE PHARMACEUTICALS IN (59935V107)
|
250,000 |
$6,788k |
|
|
CYCLERION THERAPEUTI (23255M105)
|
544,085 |
$6,230k |
|
|
SCTY 1 5/8 11/01/19 (83416TAC4)
|
5,500,000 |
$5,304k |
|
|
PERSONALIS INC (71535D106)
|
184,932 |
$5,021k |
|
|
PFENEX INC (717071104)
|
600,000 |
$4,044k |
|
|
SANOFI (80105N113)
|
6,827,805 |
$3,550k |
|
|
AKERO THERAPEUTICS INC (00973Y108)
|
150,000 |
$2,873k |
|
|
APTINYX INC COM (03836N103)
|
670,000 |
$2,238k |
|
|
GOSSAMER BIO INC (38341P102)
|
100,000 |
$2,218k |
|
|
ZAFGEN INC (98885E103)
|
1,800,000 |
$2,142k |
|
|
Assembly Biosciences Inc (045396108)
|
100,000 |
$1,349k |
|
|
ADAPTIVE BIOTECHNOLOGIES COR (00650F109)
|
25,000 |
$1,208k |
|
|
RADIUS HEALTH INC (750469AA6)
|
1,250,000 |
$1,132k |
|
|
Occidental Petroleum Corp (674599105)
|
20,000 |
$1,006k |
|
Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.
All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.
Recently Searched Firms
Please note: Search data is accumulated by 3rd party and refreshed once per day.